Holen Sie sich die Stockscreener-App
34.62
4.21%
1.40
Handel nachbörslich:
34.80
0.18
+0.52%
Heartflow Inc Aktie (HTFL) Neueste Nachrichten
HTFL Stock Price and Chart — NASDAQ:HTFL - TradingView
Heartflow (NASDAQ:HTFL) Sets New 12-Month HighShould You Buy? - MarketBeat
HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis - Yahoo Finance
Heartflow, Inc. (NASDAQ:HTFL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Why HeartFlow Stock Rocketed 14% Higher Today - MSN
Heartflow receives FDA clearance for updated plaque analysis platform - MedTech Dive
HTFL Crosses Above Average Analyst Target - Nasdaq
FDA clears Heartflow’s next-gen plaque analysis - BioWorld MedTech
Heartflow (NASDAQ:HTFL) Shares Up 10% Following Analyst Upgrade - MarketBeat
CCORF Maintains Heartflow(HTFL.US) With Buy Rating, Maintains Target Price $39 - 富途牛牛
Heartflow secures FDA clearance for updated plaque analysis platform - Yahoo Finance
Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform - BioSpace
Heartflow (NASDAQ:HTFL) Given New $39.00 Price Target at Canaccord Genuity Group - Defense World
FDA clears Heartflow’s AI plaque analysis tool, Cigna to cover it - Investing.com
FDA clears Heartflow’s AI plaque analysis tool, Cigna to cover it By Investing.com - Investing.com South Africa
Heartflow stock rises after FDA clearance for Next Gen Plaque Analysis By Investing.com - Investing.com Nigeria
Heartflow stock rises after FDA clearance for Next Gen Plaque Analysis - Investing.com Nigeria
Heartflow announces FDA 510(k) clearance and launch of next generation Heartflow Plaque Analysis platform - MarketScreener
Heartflow Announces FDA 510(K) Clearance And Launch Of Next Generation Heartflow Plaque Analysis Platform - TradingView
Heartflow Receives FDA 510(k) Clearance for Next-Gen Heartflow Plaque Analysis Platform - MarketScreener
Cigna (CI) to Cover Heartflow's Newly Approved Technology - GuruFocus
FDA Clears Heartflow Coronary Plaque Technology - MarketScreener
Heartflow announces FDA clearance of plaque analysis algorithm, Cigna coverage - TipRanks
95% Accuracy vs Gold Standard: HeartFlow's Revolutionary AI Heart Disease Platform Wins FDA Approval - Stock Titan
Heartflow (NASDAQ:HTFL) Stock Price Down 5.2% After Earnings Miss - MarketBeat
Canaccord Genuity raises Heartflow stock price target to $39 on FFRct growth - Investing.com Nigeria
Canaccord Genuity Group Issues Positive Forecast for Heartflow (NASDAQ:HTFL) Stock Price - MarketBeat
Heartflow price target raised to $39 from $35 at Canaccord - TipRanks
Heartflow (NASDAQ:HTFL) Announces Quarterly Earnings Results - MarketBeat
AI-Enabled Heart Diagnostics Put HeartFlow (HTFL) in the Spotlight - MSN
HeartFlow: Q2 Earnings Snapshot - New Haven Register
HeartFlow, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Heartflow, Inc. SEC 10-Q Report - TradingView
Stocks Generating Improved Relative Strength: Heartflow - MSN
Heartflow Completes US$364 Million Upsized IPO - Global Legal Chronicle
Heartflow, Inc.'s (NASDAQ:HTFL) Quiet Period Will Expire on September 17th - MarketBeat
HeartFlow, Inc.: Balancing Impressive Growth with Strategic Challenges – A Hold Recommendation - TipRanks
Heartflow (NASDAQ:HTFL) Shares Gap UpHere's Why - MarketBeat
HeartFlow Releases Investor Presentation at Healthcare Conference - TipRanks
Heartflow Incexpects Q2 2025 revenue of $43.4 millionSEC filing - MarketScreener
HeartFlow (HTFL): Evaluating Valuation After Recent Share Price Surge Without a Clear Catalyst - Yahoo Finance
2.78%
2.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):